British drugmaker AstraZeneca Plc said Friday it has agreed with the Japanese government to promote talks on supplying Japan with the experimental coronavirus vaccine it is jointly developing with the University of Oxford.The drugmaker's Osaka-based unit said it will cooperate with Daiichi Sankyo Co., Meiji Seika Pharma Co. and KM Biologics Co. to secure a stable supply of the vaccine for Japan, collaborating on different stages of the process from packing vials of the vaccine with components imported from overseas to storing and shipping them.In Tokyo, Chief Cabinet Secretary Yoshihide Sug…READ FULL ARTICLE
